|
|
Data submission for the second quarter (Q2) of ASCA’s 2023 Clinical & Operational Benchmarking Survey is now open. This valuable online resource provides data you can use to improve clinical outcomes, staff indicators, billing performance and more at your facility. If you haven’t already, subscribe today so you can submit your data and receive comparison data for the remaining three quarters of the year. ASCA members save $150 on subscriptions to the 2023 survey. Purchase your subscription now. |
|
|
|
Be sure to check out the latest edition of ASCA’s “ ASC Physician Brief,” a quarterly one-pager to share with both the owner and nonowner physicians who work in your ASC. The Summer 2023 edition is now available on ASCA’s website. |
|
|
The Challenges of Airway Management: A Podcast Series
Why is airway management like a maze? Is video laryngoscopy more expensive than other options? How can we make airway management safer? This podcast series answers these questions and more. Through brief, interview-style conversations, each episode focuses on a hot topic in airway management, including cost effectiveness, video laryngoscopy, and difficult airways. Choose your topic and start listening today.
|
|
|
|
Accessories and service will no longer be available for Zoll E or M Series defibrillators, as these models are end-of-life and do not meet FDA approval. ASCA members: Read more from the FDA, then reach out to ASCA affinity partner HANDLE Global for assistance in making the transition to an FDA-approved device. |
|
|
How to Know When It Is Time to Consider a Strategic Partner
When it comes to strategic partnerships, surgery centers have many options to choose from, but timing is everything. Blake Peart is the Managing Director of Vertess, and he’s on the show this week to chat about when it is the right time to consider a strategic partner, key indicators that its time, potential benefits and advantages, and identifying the right partner. Make sure to subscribe so you never miss an episode - new podcast episodes are released every Tuesday!
|
|
|
|
ASCs will see 12 percent and 22 percent growth in the next 5 and 10 years, respectively, according to Sg2’s 2023 Impact of Change Forecast Highlights. Gastroenterology, ophthalmology and orthopedic procedures will see the highest increases in cases shifting from hospitals. Read this Digital Debut to learn more. |
|
|
|
|
ASCA has posted a 2023 Q3 Medicare Payment Resources document based on the Centers for Medicare & Medicaid Services’ (CMS) July payment addenda. The payment resources document provides separate worksheets that break out the codes into groups, such as separately payable, office-based, device-intensive and more.
|
|
|
|
|
For the first time in history, Medicare has the ability to directly negotiate the prices of covered prescription drugs due to President Biden’s historic prescription drug law, the Inflation Reduction Act. Today, the Centers for Medicare & Medicaid Services (CMS) released revised guidance detailing the requirements and parameters of the new Medicare Drug Price Negotiation Program for the first round of negotiations, which will occur during 2023 and 2024 and result in prices that will be effective beginning in 2026.
|
|
CMS Press Release (06/30/23)
|
|
|
|
|
With the growing popularity of medications like Ozempic (semaglutide), Trulicity (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes and weight loss, the American Society of Anesthesiologists (ASA) suggests withholding the medication before elective surgery to reduce the risk of complications associated with anesthesia in adults and children. GLP-1 agonists are approved by the U.S. Food and Drug Administration to treat type 2 diabetes and reduce the risk of cardiovascular disease.
|
|
American Society of Anesthesiologists (06/29/2023)
|
|
|
|
|
The AHRQ Toolkit for Improving Surgical Care and Recovery addresses common surgical complications such as surgical site and urinary tract infections, and venous thromboembolism. The toolkit, created for surgical teams by surgeons, was tested in more than 300 hospitals nationwide and includes evidence-based enhanced recovery pathways for colorectal, gynecologic, hip and knee replacement, hip fracture and emergency general surgery.
|
|
AHRQ News Now (06/27/23)
|
|
|
|
|
Experienced cataract surgeons know that the most challenging cataract cases are often the nanophthalmic eyes. These tiny eyes have a very short axial length of less than 20 mm along with a shallow anterior chamber, less pupil dilation and a smaller anterior segment.
|
|
Ocular Surgery News (06/22/23) Uday Devgan
|
|
|
|
|
Sebela Pharmaceuticals today announced that the U.S. Food and Drug Administration granted approval of Suflave (polyethylene glycol, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution), for colonoscopy preparation in adults. Suflave, a low-volume, safe and effective colonoscopy preparation – with a taste similar to a lemon-lime sports drink – was developed and will be marketed by Braintree Laboratories, a leader in gastroenterology and part of Sebela Pharmaceuticals.
|
|
PR Newswire (06/22/23)
|
|
|
|
|
The celebratory ribbon was cut on June 12 by staff of the new Valley Surgery Center which is located in the Hudson Medical Center. Currently, a partnership between Associated Eye Care and Hudson Physicians, the new surgery center is set to open in the upcoming months.
|
|
Hudson Star Observer (06/22/23) Caleb Fravel
|
|
About ASCAMission: The Ambulatory Surgery Center Association (ASCA) is the national membership association that represents ambulatory surgery centers (ASCs) and provides advocacy and resources to assist ASCs in delivering high-quality, cost-effective ambulatory surgery to all the patients they serve. About Us: At ASCA, we are eager to help you become better acquainted with our nation's ASCs and the people who own and operate them. We are also eager to help you develop policies on ASC-related issues. If you have questions, please contact us. We'll put you in touch with the experts and, if you like, arrange for you to visit an ASC in your area. Contact Us: Advertising inquiries should be addressed to Chris Schriever or Alex Yewdell at 202.337.1897 or at advertising@ascassociation.org. Follow ASCA on
|
|
|
|
|